WAVE Life Sciences Ltd.
WVE
|
|
| |
|
| Trading Volume | 29,340 |
|
|
6.87 - 3.54 |
| Market Cap Full | $ 565.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 9.3% | 22.2% | -38.1% | -36.3% |
| Q2 | - | -21% | -15.9% | 62.5% |
| Q3 | - | -13.8% | 58% | 11.1% |
| Q4 | - | -24.8% | -16.1% | 93.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -14.5 | 11.3 | 28.3 | -20.9 | 26.5 | -19.4 | 32.9 | -13.8 | - | - | - | -18.2 |
| 2023 | |||||||||||
| -29.6 | -14.8 | 3.1 | -7.9 | -0.8 | -8.1 | 20.1 | -0.5 | 32.2 | -6.4 | -1.3 | -4.9 |
| 2022 | |||||||||||
| -30.3 | 12.3 | -18.7 | 7 | -34.6 | 132.1 | -21.9 | 17.3 | 21.1 | 32.7 | -11.5 | 65.1 |
| 2021 | |||||||||||
| 29.4 | -9.3 | -39.2 | 7 | 13.9 | -2.6 | -16.8 | 14.3 | -22.6 | -6.9 | -13.6 | -20.3 |
| 2020 | |||||||||||
| -13.7 | 17 | 12.9 | -7.4 | 17.3 | 2.3 | -15.7 | 42.7 | -32.2 | -16.7 | 24.8 | -10.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.6 | -0.9 | -1.4 |
| Q2 | -0.2 | -0.6 | -0.8 | -1.2 |
| Q3 | 0.1 | -0.4 | -0.1 | -0.9 |
| Q4 | 0 | -0.4 | -0.6 | -0.4 |
| A | -0.4 | -2.1 | -2.4 | -3.8 |